
====================================================================================================
MADEX BOOTSTRAP STATISTICAL VALIDATION ANALYSIS
====================================================================================================
Analysis initiated at: 2025-08-26 23:15:50
Analysis type: Bootstrap confidence interval validation for MADEX metric
Clinical context: Glucose prediction model statistical validation

ANALYSIS OBJECTIVES:
1. Generate bootstrap confidence intervals for MADEX across clinical scenarios
2. Compare MADEX performance against traditional metrics (RMSE, MAE)
3. Assess clinical risk using Clarke Error Grid Analysis
4. Evaluate statistical significance of model differences
5. Analyze hypoglycemia and hyperglycemia detection sensitivity

================================================================================
CLINICAL SCENARIO ANALYSIS
================================================================================

Scenario A: Hypoglycemia Detection
Description: Critical low glucose events (45-61 mg/dL)
Risk Level: CRITICAL
Clinical Context: Life-threatening hypoglycemia requiring immediate intervention

Scenario B: Hyperglycemia Management
Description: Sustained high glucose (275-310 mg/dL)
Risk Level: HIGH
Clinical Context: Severe hyperglycemia requiring aggressive treatment

Scenario C: Postprandial Response
Description: Meal-induced glucose spikes (115-220 mg/dL)
Risk Level: MODERATE
Clinical Context: Post-meal glucose management challenges

Scenario D: Dawn Phenomenon
Description: Early morning glucose rise (85-155 mg/dL)
Risk Level: LOW
Clinical Context: Natural circadian glucose elevation

Scenario E: Exercise Response
Description: Activity-induced glucose drop (65-140 mg/dL)
Risk Level: MODERATE
Clinical Context: Exercise-induced hypoglycemia risk

Scenario F: Measurement Noise
Description: Sensor accuracy challenges (97-105 mg/dL)
Risk Level: LOW
Clinical Context: Measurement precision in normal glucose range

Scenario G: Mixed Clinical
Description: Combined challenging scenarios (45-250 mg/dL)
Risk Level: CRITICAL
Clinical Context: Mixed critical events testing robustness

Scenario H: Extreme Cases
Description: Life-threatening glucose extremes (25-450 mg/dL)
Risk Level: CRITICAL
Clinical Context: Extreme glucose values requiring emergency care

================================================================================
BOOTSTRAP ANALYSIS EXECUTION
================================================================================
Bootstrap parameters: n_bootstrap=1000, confidence_interval=95%
MADEX parameters: a=125.0 (euglycemic center), b=55.0 (critical range), c=40.0 (slope modifier)
Total scenarios to analyze: 8

INITIATING SCENARIO-BY-SCENARIO ANALYSIS:
--------------------------------------------------

[1/8] ANALYZING SCENARIO A: Hypoglycemia Detection
Clinical Context: Life-threatening hypoglycemia requiring immediate intervention
Risk Level: CRITICAL
Data points: 8, Glucose range: 45.0-61.0 mg/dL
Model A predictions: 65.0-80.0 mg/dL
Model B predictions: 35.0-51.0 mg/dL
Computing bootstrap confidence intervals (n=1000)...
Bootstrap results computed:
  MADEX - Model A: 1242.81 (997.24-1479.36)
  MADEX - Model B: 60.87 (60.30-61.45)
  RMSE - Model A: 18.94 (17.68-19.88)
  RMSE - Model B: 10.00 (10.00-10.00)
Performing Clarke Error Grid Analysis...
Clarke Error Grid zones - Model A: ['A (Accurate): 4', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 4', 'E (Erroneous): 0']
Clarke Error Grid zones - Model B: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clinical risk scores: Model A = 20, Model B = 0
[CLINICAL ASSESSMENT] Model B has lower clinical risk (better safety profile)
[MADEX ASSESSMENT] Model B shows better MADEX performance (60.87 vs 1242.81)
[SUCCESS] MADEX confidence intervals do not overlap - significant difference detected

[2/8] ANALYZING SCENARIO B: Hyperglycemia Management
Clinical Context: Severe hyperglycemia requiring aggressive treatment
Risk Level: HIGH
Data points: 8, Glucose range: 275.0-310.0 mg/dL
Model A predictions: 245.0-280.0 mg/dL
Model B predictions: 315.0-350.0 mg/dL
Computing bootstrap confidence intervals (n=1000)...
Bootstrap results computed:
  MADEX - Model A: 11392.82 (11354.70-11428.84)
  MADEX - Model B: 40.74 (40.53-40.96)
  RMSE - Model A: 30.00 (30.00-30.00)
  RMSE - Model B: 40.00 (40.00-40.00)
Performing Clarke Error Grid Analysis...
Clarke Error Grid zones - Model A: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clarke Error Grid zones - Model B: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clinical risk scores: Model A = 0, Model B = 0
[CLINICAL ASSESSMENT] Both models have equivalent clinical risk
[MADEX ASSESSMENT] Model B shows better MADEX performance (40.74 vs 11392.82)
[SUCCESS] MADEX confidence intervals do not overlap - significant difference detected

[3/8] ANALYZING SCENARIO C: Postprandial Response
Clinical Context: Post-meal glucose management challenges
Risk Level: MODERATE
Data points: 8, Glucose range: 115.0-220.0 mg/dL
Model A predictions: 105.0-210.0 mg/dL
Model B predictions: 125.0-230.0 mg/dL
Computing bootstrap confidence intervals (n=1000)...
Bootstrap results computed:
  MADEX - Model A: 128.61 (106.94-149.55)
  MADEX - Model B: 82.01 (68.88-96.05)
  RMSE - Model A: 10.00 (10.00-10.00)
  RMSE - Model B: 10.00 (10.00-10.00)
Performing Clarke Error Grid Analysis...
Clarke Error Grid zones - Model A: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clarke Error Grid zones - Model B: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clinical risk scores: Model A = 0, Model B = 0
[CLINICAL ASSESSMENT] Both models have equivalent clinical risk
[MADEX ASSESSMENT] Model B shows better MADEX performance (82.01 vs 128.61)
[SUCCESS] MADEX confidence intervals do not overlap - significant difference detected

[4/8] ANALYZING SCENARIO D: Dawn Phenomenon
Clinical Context: Natural circadian glucose elevation
Risk Level: LOW
Data points: 8, Glucose range: 85.0-155.0 mg/dL
Model A predictions: 90.0-160.0 mg/dL
Model B predictions: 80.0-150.0 mg/dL
Computing bootstrap confidence intervals (n=1000)...
Bootstrap results computed:
  MADEX - Model A: 24.99 (23.57-26.45)
  MADEX - Model B: 25.17 (23.77-26.42)
  RMSE - Model A: 5.00 (5.00-5.00)
  RMSE - Model B: 5.00 (5.00-5.00)
Performing Clarke Error Grid Analysis...
Clarke Error Grid zones - Model A: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clarke Error Grid zones - Model B: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clinical risk scores: Model A = 0, Model B = 0
[CLINICAL ASSESSMENT] Both models have equivalent clinical risk
[MADEX ASSESSMENT] Model A shows better MADEX performance (24.99 vs 25.17)
[WARNING] MADEX confidence intervals overlap - difference may not be statistically significant

[5/8] ANALYZING SCENARIO E: Exercise Response
Clinical Context: Exercise-induced hypoglycemia risk
Risk Level: MODERATE
Data points: 8, Glucose range: 65.0-140.0 mg/dL
Model A predictions: 70.0-145.0 mg/dL
Model B predictions: 60.0-135.0 mg/dL
Computing bootstrap confidence intervals (n=1000)...
Bootstrap results computed:
  MADEX - Model A: 27.01 (25.58-28.29)
  MADEX - Model B: 23.28 (22.21-24.56)
  RMSE - Model A: 5.00 (5.00-5.00)
  RMSE - Model B: 5.00 (5.00-5.00)
Performing Clarke Error Grid Analysis...
Clarke Error Grid zones - Model A: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clarke Error Grid zones - Model B: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clinical risk scores: Model A = 0, Model B = 0
[CLINICAL ASSESSMENT] Both models have equivalent clinical risk
[MADEX ASSESSMENT] Model B shows better MADEX performance (23.28 vs 27.01)
[SUCCESS] MADEX confidence intervals do not overlap - significant difference detected

[6/8] ANALYZING SCENARIO F: Measurement Noise
Clinical Context: Measurement precision in normal glucose range
Risk Level: LOW
Data points: 8, Glucose range: 97.0-105.0 mg/dL
Model A predictions: 105.0-113.0 mg/dL
Model B predictions: 89.0-97.0 mg/dL
Computing bootstrap confidence intervals (n=1000)...
Bootstrap results computed:
  MADEX - Model A: 76.09 (75.31-76.86)
  MADEX - Model B: 53.86 (53.30-54.43)
  RMSE - Model A: 8.00 (8.00-8.00)
  RMSE - Model B: 8.00 (8.00-8.00)
Performing Clarke Error Grid Analysis...
Clarke Error Grid zones - Model A: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clarke Error Grid zones - Model B: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clinical risk scores: Model A = 0, Model B = 0
[CLINICAL ASSESSMENT] Both models have equivalent clinical risk
[MADEX ASSESSMENT] Model B shows better MADEX performance (53.86 vs 76.09)
[SUCCESS] MADEX confidence intervals do not overlap - significant difference detected

[7/8] ANALYZING SCENARIO G: Mixed Clinical
Clinical Context: Mixed critical events testing robustness
Risk Level: CRITICAL
Data points: 8, Glucose range: 45.0-250.0 mg/dL
Model A predictions: 55.0-260.0 mg/dL
Model B predictions: 35.0-240.0 mg/dL
Computing bootstrap confidence intervals (n=1000)...
Bootstrap results computed:
  MADEX - Model A: 109.59 (76.41-143.22)
  MADEX - Model B: 111.52 (76.35-146.63)
  RMSE - Model A: 10.00 (10.00-10.00)
  RMSE - Model B: 10.00 (10.00-10.00)
Performing Clarke Error Grid Analysis...
Clarke Error Grid zones - Model A: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clarke Error Grid zones - Model B: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clinical risk scores: Model A = 0, Model B = 0
[CLINICAL ASSESSMENT] Both models have equivalent clinical risk
[MADEX ASSESSMENT] Model A shows better MADEX performance (109.59 vs 111.52)
[WARNING] MADEX confidence intervals overlap - difference may not be statistically significant

[8/8] ANALYZING SCENARIO H: Extreme Cases
Clinical Context: Extreme glucose values requiring emergency care
Risk Level: CRITICAL
Data points: 8, Glucose range: 25.0-450.0 mg/dL
Model A predictions: 45.0-430.0 mg/dL
Model B predictions: 15.0-470.0 mg/dL
Computing bootstrap confidence intervals (n=1000)...
Bootstrap results computed:
  MADEX - Model A: 1701.88 (1639.79-1761.30)
  MADEX - Model B: 73.98 (62.39-81.97)
  RMSE - Model A: 20.00 (20.00-20.00)
  RMSE - Model B: 15.65 (11.73-19.04)
Performing Clarke Error Grid Analysis...
Clarke Error Grid zones - Model A: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clarke Error Grid zones - Model B: ['A (Accurate): 8', 'B (Acceptable): 0', 'C (Overcorrecting): 0', 'D (Failure to Detect): 0', 'E (Erroneous): 0']
Clinical risk scores: Model A = 0, Model B = 0
[CLINICAL ASSESSMENT] Both models have equivalent clinical risk
[MADEX ASSESSMENT] Model B shows better MADEX performance (73.98 vs 1701.88)
[SUCCESS] MADEX confidence intervals do not overlap - significant difference detected

================================================================================
STATISTICAL SIGNIFICANCE TESTING
================================================================================
Performing Wilcoxon signed-rank tests across all scenarios
Testing hypothesis: Model A vs Model B performance differences

WILCOXON SIGNED-RANK TEST RESULTS:
---------------------------------------------

MADEX Statistical Analysis:
  Wilcoxon statistic: 3.00
  P-value: 0.0391
  Cohen's d (effect size): 0.45
  [SUCCESS] significant (p < 0.05) - Evidence of difference
  Effect size interpretation: small effect size
  [INTERPRETATION] Model B shows better MADEX performance on average

RMSE Statistical Analysis:
  Wilcoxon statistic: 3.00
  P-value: 1.0000
  Cohen's d (effect size): 0.08
  [WARNING] not significant (p >= 0.10) - No evidence of difference
  Effect size interpretation: negligible effect size
  [INTERPRETATION] Model B shows better RMSE performance on average

MAE Statistical Analysis:
  Wilcoxon statistic: 3.00
  P-value: 1.0000
  Cohen's d (effect size): 0.09
  [WARNING] not significant (p >= 0.10) - No evidence of difference
  Effect size interpretation: negligible effect size
  [INTERPRETATION] Model B shows better MAE performance on average

================================================================================
CLINICAL DETECTION SENSITIVITY ANALYSIS
================================================================================
Evaluating model sensitivity for critical glucose events
This analysis assesses how well models detect dangerous glucose levels

HYPOGLYCEMIA DETECTION SENSITIVITY (<70 mg/dL):
--------------------------------------------------
Hypoglycemia is life-threatening and requires immediate detection
Sensitivity = True Positives / (True Positives + False Negatives)

Scenario A (Hypoglycemia Detection) Hypoglycemia Detection:
  Model A sensitivity: 0.25 (25.0%)
  Model B sensitivity: 1.00 (100.0%)
  [CLINICAL] Model B better at detecting hypoglycemia (safer)
  [SUCCESS] Excellent hypoglycemia detection capability (>=90%)

Scenario B (Hyperglycemia Management): No hypoglycemic events to detect

Scenario E (Exercise Response) Hypoglycemia Detection:
  Model A sensitivity: 0.00 (0.0%)
  Model B sensitivity: 1.00 (100.0%)
  [CLINICAL] Model B better at detecting hypoglycemia (safer)
  [SUCCESS] Excellent hypoglycemia detection capability (>=90%)

Scenario G (Mixed Clinical) Hypoglycemia Detection:
  Model A sensitivity: 0.67 (66.7%)
  Model B sensitivity: 1.00 (100.0%)
  [CLINICAL] Model B better at detecting hypoglycemia (safer)
  [SUCCESS] Excellent hypoglycemia detection capability (>=90%)

Scenario H (Extreme Cases) Hypoglycemia Detection:
  Model A sensitivity: 1.00 (100.0%)
  Model B sensitivity: 1.00 (100.0%)
  [CLINICAL] Both models equivalent for hypoglycemia detection
  [SUCCESS] Excellent hypoglycemia detection capability (>=90%)

HYPERGLYCEMIA DETECTION SENSITIVITY (>180 mg/dL):
--------------------------------------------------
Hyperglycemia detection is crucial for preventing diabetic complications
High glucose levels require prompt intervention to prevent ketoacidosis

Scenario A (Hypoglycemia Detection): No hyperglycemic events to detect

Scenario B (Hyperglycemia Management) Hyperglycemia Detection:
  Model A sensitivity: 1.00 (100.0%)
  Model B sensitivity: 1.00 (100.0%)
  [CLINICAL] Both models equivalent for hyperglycemia detection
  [SUCCESS] Excellent hyperglycemia detection capability (>=90%)

Scenario C (Postprandial Response) Hyperglycemia Detection:
  Model A sensitivity: 1.00 (100.0%)
  Model B sensitivity: 1.00 (100.0%)
  [CLINICAL] Both models equivalent for hyperglycemia detection
  [SUCCESS] Excellent hyperglycemia detection capability (>=90%)

Scenario G (Mixed Clinical) Hyperglycemia Detection:
  Model A sensitivity: 1.00 (100.0%)
  Model B sensitivity: 1.00 (100.0%)
  [CLINICAL] Both models equivalent for hyperglycemia detection
  [SUCCESS] Excellent hyperglycemia detection capability (>=90%)

Scenario H (Extreme Cases) Hyperglycemia Detection:
  Model A sensitivity: 1.00 (100.0%)
  Model B sensitivity: 1.00 (100.0%)
  [CLINICAL] Both models equivalent for hyperglycemia detection
  [SUCCESS] Excellent hyperglycemia detection capability (>=90%)

====================================================================================================
BOOTSTRAP VALIDATION ANALYSIS SUMMARY
====================================================================================================
Analysis completed at: 2025-08-26 23:15:53
Total scenarios analyzed: 8
Bootstrap samples per metric: 1000
Confidence interval level: 95%

KEY FINDINGS:
---------------
1. MADEX Statistical Significance: p=0.0391
   [SUCCESS] MADEX shows statistically significant model differences
2. Traditional Metrics Comparison:
   RMSE p-value: 1.0000
   MAE p-value: 1.0000
   [SUCCESS] MADEX more sensitive than traditional metrics
3. Hypoglycemia Detection Performance:
   Model A average sensitivity: 0.48 (47.9%)
   Model B average sensitivity: 1.00 (100.0%)
   [CLINICAL RECOMMENDATION] Model B preferred for hypoglycemia detection
4. Hyperglycemia Detection Performance:
   Model A average sensitivity: 1.00 (100.0%)
   Model B average sensitivity: 1.00 (100.0%)

CONCLUSIONS:
------------
This bootstrap validation provides statistical confidence intervals for MADEX
and traditional metrics across clinically relevant glucose prediction scenarios.
The analysis enables evidence-based model selection for glucose monitoring systems.

[ANALYSIS COMPLETE] Bootstrap validation analysis finished successfully.
Results logged to bootstrap_llm_narrative.log for LLM consumption.
